哈佛大学商学院的里贾纳·赫茨琳杰(ReginaHerzlinger)仔细算了笔总帐。 她确信,花费数十亿美元开发新药的时代已经到来。
Regina Herzlinger, of Harvard Business School, has scrutinised the sums and is certain the era of the billion-dollar new drug has arrived.
哈佛大学商学院的里贾纳·赫茨琳杰(ReginaHerzlinger)仔细算了笔总帐。 她确信,花费数十亿美元开发新药的时代已经到来。
Regina Herzlinger, of Harvard Business School, has scrutinised the sums and is certain the era of the billion-dollar new drug has arrived.
应用推荐